• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激活素和激活素拮抗剂在前列腺和前列腺癌中的作用。

Activins and activin antagonists in the prostate and prostate cancer.

机构信息

Department of Anatomy and Structural Biology, University of Otago, Dunedin, New Zealand.

出版信息

Mol Cell Endocrinol. 2012 Aug 15;359(1-2):107-12. doi: 10.1016/j.mce.2011.07.005. Epub 2011 Jul 20.

DOI:10.1016/j.mce.2011.07.005
PMID:21787836
Abstract

Activins are members of the TGF-β super-family. There are 4 mammalian activin subunits (β(A), β(B), β(C) and β(E)) that combine to form functional proteins. The role of activin A (β(A)β(A)) is well characterized and known to be a potent growth and differentiation factor. Two of the activin subunits (β(C) and β(E)) were discovered more recently and little is known about their biological functions. In this review the evidence that activin-β(C) is a significant regulator of activin A bioactivity is presented and discussed. It is concluded that activin-β(C), like other antagonists of activin A, is an important growth regulator in prostate health and disease.

摘要

激活素是 TGF-β 超家族的成员。哺乳动物中有 4 种激活素亚基(β(A)、β(B)、β(C)和β(E)),它们可以组合形成有功能的蛋白。激活素 A(β(A)β(A))的作用已经得到很好的描述,被认为是一种有效的生长和分化因子。最近发现了其中的两种激活素亚基(β(C)和β(E)),但它们的生物学功能知之甚少。本文综述了激活素-β(C)是激活素 A 生物活性的重要调节剂的证据,并对其进行了讨论。结论认为,激活素-β(C)与其他激活素 A 的拮抗剂一样,是前列腺健康和疾病中重要的生长调节剂。

相似文献

1
Activins and activin antagonists in the prostate and prostate cancer.激活素和激活素拮抗剂在前列腺和前列腺癌中的作用。
Mol Cell Endocrinol. 2012 Aug 15;359(1-2):107-12. doi: 10.1016/j.mce.2011.07.005. Epub 2011 Jul 20.
2
Regulation of prostate branching morphogenesis by activin A and follistatin.激活素A和卵泡抑素对前列腺分支形态发生的调节
Dev Biol. 2001 Sep 1;237(1):145-58. doi: 10.1006/dbio.2001.0364.
3
Localization of activin beta(A)-, beta(B)-, and beta(C)-subunits in humanprostate and evidence for formation of new activin heterodimers of beta(C)-subunit.激活素β(A)-、β(B)-和β(C)-亚基在人前列腺中的定位以及β(C)-亚基新激活素异二聚体形成的证据。
J Clin Endocrinol Metab. 2000 Dec;85(12):4851-8. doi: 10.1210/jcem.85.12.7052.
4
Differential binding and neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-3/FSRP/FLRG).卵泡抑素和卵泡抑素样-3(FSTL-3/FSRP/FLRG)对激活素A和B的差异结合与中和作用
Endocrinology. 2003 May;144(5):1671-4. doi: 10.1210/en.2002-0203.
5
Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues.人前列腺肿瘤组织中激活素受体、抑制素/激活素亚基及卵泡抑素mRNA的变化
Br J Cancer. 2000 Jan;82(1):112-7. doi: 10.1054/bjoc.1999.0886.
6
Expression and localization of activin subunits and follistatins in tissues from men with high grade prostate cancer.激活素亚基和卵泡抑素在高级别前列腺癌男性组织中的表达与定位
J Clin Endocrinol Metab. 1997 Nov;82(11):3851-8. doi: 10.1210/jcem.82.11.4374.
7
Activin-related proteins in bovine mammary gland: localization and differential expression during gestational development and differentiation.牛乳腺中激活素相关蛋白:在妊娠发育和分化过程中的定位和差异表达。
J Dairy Sci. 2010 Oct;93(10):4592-601. doi: 10.3168/jds.jds.2009-2981.
8
Regulation of prostate-specific antigen by activin A in prostate cancer LNCaP cells.激活素A对前列腺癌LNCaP细胞中前列腺特异性抗原的调控
Am J Physiol Endocrinol Metab. 2004 Jun;286(6):E927-31. doi: 10.1152/ajpendo.00443.2003. Epub 2004 Feb 3.
9
The contribution of inhibins and activins to malignant prostate disease.抑制素和激活素在前列腺恶性疾病中的作用。
Mol Cell Endocrinol. 2001 Jun 30;180(1-2):149-53. doi: 10.1016/s0303-7207(01)00497-x.
10
Purification of recombinant activin A using the second follistatin domain of follistatin-related gene (FLRG).利用卵泡抑素相关基因(FLRG)的第二个卵泡抑素结构域纯化重组激活素A。
Protein Expr Purif. 2006 Sep;49(1):78-82. doi: 10.1016/j.pep.2006.04.003. Epub 2006 Apr 25.

引用本文的文献

1
Advances in Urological Cancer in 2022, from Basic Approaches to Clinical Management.2022年泌尿生殖系统癌症进展:从基础研究到临床管理
Cancers (Basel). 2023 Feb 23;15(5):1422. doi: 10.3390/cancers15051422.
2
Macrophages promote anti-androgen resistance in prostate cancer bone disease.巨噬细胞促进前列腺癌骨病中的抗雄激素耐药性。
J Exp Med. 2023 Apr 3;220(4). doi: 10.1084/jem.20221007. Epub 2023 Feb 7.
3
Integrative characterisation of secreted factors involved in intercellular communication between prostate epithelial or cancer cells and fibroblasts.
整合鉴定前列腺上皮细胞或癌细胞与成纤维细胞之间细胞间通讯相关分泌因子。
Mol Oncol. 2023 Mar;17(3):469-486. doi: 10.1002/1878-0261.13376. Epub 2023 Jan 27.
4
Intra-epithelial non-canonical Activin A signaling safeguards prostate progenitor quiescence.上皮细胞内非经典激活素 A 信号通路保障前列腺祖细胞静止状态。
EMBO Rep. 2022 May 4;23(5):e54049. doi: 10.15252/embr.202154049. Epub 2022 Mar 7.
5
Profiling Activins and Follistatin in Colorectal Cancer According to Clinical Stage, Tumour Sidedness and Smad4 Status.根据临床分期、肿瘤侧别和 Smad4 状态对结直肠癌中的激活素和卵泡抑素进行分析。
Pathol Oncol Res. 2021 Nov 15;27:1610032. doi: 10.3389/pore.2021.1610032. eCollection 2021.
6
A NF-ĸB-Activin A signaling axis enhances prostate cancer metastasis.NF-κB-Activin A 信号轴增强前列腺癌转移。
Oncogene. 2020 Feb;39(8):1634-1651. doi: 10.1038/s41388-019-1103-0. Epub 2019 Nov 18.
7
Kangquan Recipe Regulates the Expression of BAMBI Protein via the TGF-/Smad Signaling Pathway to Inhibit Benign Prostatic Hyperplasia in Rats.康泉方通过TGF-β/Smad信号通路调控BAMBI蛋白表达以抑制大鼠良性前列腺增生
Evid Based Complement Alternat Med. 2019 May 2;2019:6281819. doi: 10.1155/2019/6281819. eCollection 2019.
8
Activin A regulates the epidermal growth factor receptor promoter by activating the PI3K/SP1 pathway in oral squamous cell carcinoma cells.激活素 A 通过激活口腔鳞状细胞癌细胞中的 PI3K/SP1 通路调节表皮生长因子受体启动子。
Sci Rep. 2019 Mar 26;9(1):5197. doi: 10.1038/s41598-019-41396-7.
9
Activin A induces apoptosis of mouse myeloma cells via the mitochondrial pathway.激活素A通过线粒体途径诱导小鼠骨髓瘤细胞凋亡。
Oncol Lett. 2018 Feb;15(2):2590-2594. doi: 10.3892/ol.2017.7584. Epub 2017 Dec 11.
10
Over-Expression of Activin-β Is Associated with Murine and Human Prostate Disease.激活素-β的过表达与小鼠和人类前列腺疾病相关。
Horm Cancer. 2017 Apr;8(2):100-107. doi: 10.1007/s12672-017-0283-8. Epub 2017 Jan 23.